Listing 3 - Actual negotiations

Indication:

Neuromyelitis optica spectrum disorder (NMOSD)

Indication:

For the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with or are not considered candidates for available standard therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF agent, an anti-EGFR agent (if RAS wild-type), and either trifluridine-tipiracil or regorafenib.

Indication:

Chronic Hepatitis B virus

Indication:

As selective internal radiation therapy (SIRT) for local tumor control of solitary tumors in patients with intermediate- or advanced-stage hepatocellular carcinoma (HCC), including those with recurrent or unresectable HCC. In addition to HCC

Indication:

For the treatment of adult patients with primary advanced or recurrent endometrial carcinoma, in combination with carboplatin and paclitaxel and then continued as monotherapy.

Indication:

Diabetes Mellitus, Type 2

Indication:

Retinal vein occlusion

Indication:

In combination with Venclexta, for the treatment of patients with previously untreated chronic lymphocytic leukemia

Indication:

In combination with Gazyva, for the treatment of patients with previously untreated chronic lymphocytic leukemia

Indication:

Multiple Indications